RN
RNVA.US Rennova Health Inc
- Market cap
- USD 4.31M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2024.
Is RNVA.US undervalued?
Graham numberThe Graham number of Rennova Health Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Rennova Health Inc fundamental analysis
No fundamental analysis for Rennova Health Inc yet.
Rennova Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Rennova Health Inc
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a hospital located in Jamestown, Tennessee. The company is based in West Palm Beach, Florida.
Full company profileRennova Health Inc financial statements
Rennova Health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 18.4M | 3.34M | 3.09M | 14.5M | 16.0M | 7.20M | 3.22M | 13.0M | 18.7M | 18.7M |
| Gross Profit | 5.89M | -322K | 424K | 3.04M | 449K | -4.58M | -2.07M | 6.27M | 11.1M | 11.1M |
| Operating Income | -25.3M | -21.5M | -16.1M | -13.1M | -15.7M | -17.2M | -12.5M | -1.41M | 1.37M | 1.37M |
| EBITDA | -39.6M | -14.7M | -26.8M | 9.98M | -24.1M | -8.41M | -1.26M | -310K | 1.45M | 1.45M |
| Net Income | -36.0M | -32.6M | -55.2M | -14.0M | -48.0M | -18.3M | 5.61M | -3.29M | -7.73M | -7.73M |
| EPS | -1,303 | -452 | -18,399,314 | -1,091 | -47,938 | -6,113 | 10 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 29.4M | 6.48M | 6.29M | 14.2M | 14.7M | 12.3M | 19.6M | 20.6M | 20.3M | 20.3M |
| Total Liabilities | 30.6M | 21.4M | 41.1M | 53.4M | 83.6M | 61.3M | 46.9M | 49.7M | 57.1M | 57.1M |
| Shareholders' Equity | -1.19M | -14.9M | -34.8M | -39.2M | -68.9M | -49.0M | -27.3M | -29.1M | -36.8M | -36.8M |
| Cash & Short-term Investments | 8.83M | 78.0K | -2.08M | 6.87K | 16.9K | 25.4K | 725K | 499K | 49.0K | 49.0K |
| Total Debt | 12.0M | 12.9M | 15.5M | - | 50.2M | 22.0M | 16.1M | 15.1M | - | 11.8M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -12.6M | -19.9M | -17.7M | -7.68M | -13.5M | -16.9M | -8.91M | -218K | 3.39M | 3.39M |
| Capital Expenditure | 456K | 18.1K | 1.42M | 213K | 125.00 | 371K | 35.2K | 35.2K | 351K | 351K |
| Free Cash Flow | -13.0M | -19.9M | -19.1M | -7.89M | -13.5M | -17.3M | -8.91M | -254K | 3.04M | 3.04M |
| Ratios | ||||||||||
| ROA | -122.4% | -503.1% | -877.4% | -98.8% | -326.6% | -149.6% | 28.5% | -16.0% | -38.2% | -38.2% |
| Net Profit Margin | -195.5% | -976.9% | -1,787.4% | -96.4% | -300.1% | -254.7% | 173.9% | -25.3% | -41.4% | -41.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Rennova Health Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 9.00M | 16 | 160.6% |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | USD 24.5M | 8,169,167 | - |
| 2016 | USD 16.3M | 226 | - |
| 2015 | USD 441K | 16 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10000 on Mar 16, 2022.
Who owns Rennova Health Inc
- Insiders 0.00%
- Institutions 9.99%
- Public & others 90.01%
- Shares outstanding 43.1B
- Free float 7.97B
Rennova Health Inc company profile
- Company name
- Rennova Health Inc
- Ticker
- RNVA.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 96
- Fiscal year end
- December
- Address
- 477 South Rosemary Avenue, West Palm Beach, FL, United States, 33401
- Phone
- 561 855 1626
- Website
- rennovahealth.com
About Rennova Health Inc
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a hospital located in Jamestown, Tennessee. The company is based in West Palm Beach, Florida.
Rennova Health Inc management
4- Mr. Seamus LaganPresident, CEO, Interim CFO & Director · born 1969
- Ms. Karen TaylorDirector of Human Resources
- Mr. Sebastien SainsburyCompany Secretary & Public Relations
- Ms. Kristine DymondTreasurer